KPIs & Operating Metrics(New)
Balance Sheet
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageDebt RatioDebt to EquityEnterprise ValueEquity AverageEquity RatioInventory AverageInvested Capital

Novartis Ag (NVS) Invested Capital (2017 - 2025)

Novartis Ag's Invested Capital history spans 9 years, with the latest figure at $48.5 billion for Q4 2025.

  • For Q4 2025, Invested Capital changed 0.31% year-over-year to $48.5 billion; the TTM value through Dec 2025 reached $48.5 billion, changed 0.31%, while the annual FY2025 figure was $48.5 billion, 0.31% changed from the prior year.
  • Invested Capital for Q4 2025 was $48.5 billion at Novartis Ag, roughly flat from $48.6 billion in the prior quarter.
  • Across five years, Invested Capital topped out at $69.7 billion in Q4 2021 and bottomed at $48.5 billion in Q4 2025.
  • The 5-year median for Invested Capital is $48.6 billion (2024), against an average of $55.1 billion.
  • The largest annual shift saw Invested Capital surged 1557.98% in 2021 before it dropped 19.42% in 2023.
  • A 5-year view of Invested Capital shows it stood at $69.7 billion in 2021, then decreased by 13.53% to $60.3 billion in 2022, then decreased by 19.42% to $48.6 billion in 2023, then increased by 0.08% to $48.6 billion in 2024, then dropped by 0.31% to $48.5 billion in 2025.
  • Per Business Quant, the three most recent readings for NVS's Invested Capital are $48.5 billion (Q4 2025), $48.6 billion (Q4 2024), and $48.6 billion (Q4 2023).